Myriad Genetics (MYGN) Cash from Investing Activities Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Cash from Investing Activities Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn | 156.94% |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn | -3,832.95% |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn | 24.18% |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn | 32.46% |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn | -10.12% |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn | -91.12% |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn | -148.98% |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn | 95.92% |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn | -8.06% |
| 10 | Myriad Genetics | 295.16 Mn | 170.76 Mn | 137.60 Mn | 21.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.69% |
| Dec 31, 2025 | -1.69% |
| Sep 30, 2025 | -182.67% |
| Jun 30, 2025 | -7.81% |
| Mar 31, 2025 | -16.90% |
| Dec 31, 2024 | 50.83% |
| Sep 30, 2024 | 400.00% |
| Jun 30, 2024 | -154.24% |
| Mar 31, 2024 | -120.52% |
| Dec 31, 2023 | 66.29% |
| Sep 30, 2023 | -121.93% |
| Jun 30, 2023 | 198.33% |
| Mar 31, 2023 | 183.78% |
| Dec 31, 2022 | -37.45% |
| Sep 30, 2022 | -96.08% |
| Jun 30, 2022 | -1,190.91% |
| Mar 31, 2022 | -603.66% |
| Dec 31, 2021 | -192.50% |
| Sep 30, 2021 | 475.10% |
| Jun 30, 2021 | -96.73% |